IMMUDEX Trademark

Trademark Overview


On Thursday, June 28, 2018, a trademark application was filed for IMMUDEX with the United States Patent and Trademark Office. The USPTO has given the IMMUDEX trademark a serial number of 88019409. The federal status of this trademark filing is REGISTERED as of Tuesday, April 14, 2020. This trademark is owned by Immudex ApS. The IMMUDEX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relat...

Chemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research pur...

Scientific research services; diagnostic services related to scientific research; basic research and clinical research in relation to medicine and vaccine development; research and development in the field of diagnostic preparations
immudex

General Information


Serial Number88019409
Word MarkIMMUDEX
Filing DateThursday, June 28, 2018
Status700 - REGISTERED
Status DateTuesday, April 14, 2020
Registration Number6031798
Registration DateTuesday, April 14, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2020

Trademark Statements


Goods and ServicesPreparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, including cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other medical therapies, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases, and for use in connection with medical procedures and diagnosis, namely transplantation, immune monitoring, and vaccines and T-cell monitoring
Goods and ServicesChemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research purposes of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis for research purposes of infectious diseases, autoimmunity and for use in connection with toxicological studies and research in relation to transplantation, immune monitoring, vaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes
Goods and ServicesScientific research services; diagnostic services related to scientific research; basic research and clinical research in relation to medicine and vaccine development; research and development in the field of diagnostic preparations

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, July 3, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 3, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 3, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmudex ApS
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressVirum DK-2830
DK

Party NameImmudex ApS
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKøbenhavn Ø DK-2100
DK

Party NameImmudex ApS
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKøbenhavn Ø DK-2100
DK

Trademark Events


Event DateEvent Description
Friday, April 14, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 14, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, April 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 14, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 12, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 12, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 12, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 12, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 12, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 14, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, March 11, 20201(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, March 11, 2020NOTICE OF ALLOWANCE CANCELLED
Tuesday, March 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 29, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 29, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 22, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, May 24, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, May 24, 2019FINAL REFUSAL E-MAILED
Friday, May 24, 2019FINAL REFUSAL WRITTEN
Monday, May 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2019ASSIGNED TO LIE
Thursday, April 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 26, 2018NON-FINAL ACTION E-MAILED
Friday, October 26, 2018NON-FINAL ACTION WRITTEN
Thursday, October 18, 2018ASSIGNED TO EXAMINER
Tuesday, July 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 2, 2018NEW APPLICATION ENTERED